|
|
|
| Clinical Value of RDW and NLR in Predicting Recurrence Risk of Glandular Cystitis Patients after Transurethral Plasmakinetic Resection |
| YU Quanfeng, LUO Rongtuan, GAO Ke |
| Department of Urology, the Second People's Hospital of Pingdingshan City, Pingdingshan Henan 467000 |
|
|
|
|
Abstract 【Objective】 To explore the clinical value of red blood cell distribution width(RDW) and neutrophil-to-lymphocyte ratio(NLR) in predicting the recurrence risk of patients with glandular cystitis after transurethral plasmakinetic resection.【Methods】 A total of 184 patients with glandular cystitis who underwent transurethral plasmakinetic resection in our hospital from July 2019 to July 2022 were selected. According to the recurrence status, the patients were divided into the recurrence group(n=27) and the non-recurrence group(n=157). The levels of RDW and NLR before and after treatment were compared. Logistic multivariate regression analysis was used to identify the risk factors for postoperative recurrence of glandular cystitis. Receiver operating characteristic(ROC) curve was used to evaluate the clinical value of RDW and NLR in predicting postoperative recurrence of glandular cystitis.【Results】 After treatment, the levels of RDW and NLR in patients were lower than those before treatment, with statistically significant differences(P<0.05). The proportions of urinary tract infection, urinary calculi, high-risk clinical type, diffuse lesion location, and the levels of RDW and NLR in the recurrence group were higher than those in the non-recurrence group, with statistically significant differences(P<0.05). Logistic multivariate regression analysis showed that high-risk clinical type, high RDW level, and high NLR level were risk factors for recurrence of glandular cystitis after transurethral plasmakinetic resection(P<0.05). ROC curve results showed that the sensitivity and specificity of combined detection of RDW and NLR in predicting postoperative recurrence of glandular cystitis were 77.8% and 86.6% respectively, and the area under the ROC curve(AUC) was 0.865, which were better than those of either single detection(P<0.05).【Conclusion】 High levels of RDW and NLR are closely related to the increased recurrence risk of glandular cystitis. The combined detection of RDW and NLR has high sensitivity and specificity for predicting recurrence, and can be used as an effective predictive tool.
|
|
Received: 26 November 2024
|
|
|
|
|
|
[1] 苏醒,高学林,马帅军,等. 腺性膀胱炎患者经尿道病损电切术后复发的危险因素[J].现代泌尿外科杂志,2022,27(8):635-640. [2] 李健,方伟林,宋奇翔,等. 经尿道膀胱肿物电切术治疗腺性膀胱炎疗效的评估及影响因素分析[J].现代泌尿外科杂志,2024,29(8):719-722. [3] 刁建伟,陈从波,李昊,等. 最大限度电切联合腹腔镜下输尿管膀胱再植术治疗高危型腺性膀胱炎伴输尿管末端狭窄临床分析[J].临床外科杂志,2023,31(1):77-79. [4] 李卿英. 膀胱尿路上皮细胞癌患者外周血NLR、PLR、MLR和RDW水平表达及在临床分期评估中的价值[J].现代检验医学杂志,2020,35(4):89-93. [5] 吴明亮,李春茂,张杰,等. NLR、IL-10水平在膀胱癌中的临床意义及对术后1年内肿瘤复发的预测效能[J].国际泌尿系统杂志,2024,44(5):851-855. [6] 李昊,姚启盛,陈从波,等. MAGE-A1蛋白在腺性膀胱炎与膀胱癌中的表达及临床意义[J].医学临床研究,2019,36(5):945-947. [7] 文亚威,曹祥明,许锋. 冬凌草热灌注与吉西他滨热灌注在腺性膀胱炎患者电切术后的应用效果[J].河南医学研究,2023,32(10):1763-1766. [8] 王蓬勃,孔朝辉,张灏,等. 膀胱热灌注联合膀胱灌注透明质酸钠液治疗腺性膀胱炎的临床疗效分析[J].医药论坛杂志,2022,43(9):45-48. [9] 魏华,唐军,黄芹,等. 八正方联合羟基喜树碱膀胱灌注治疗腺性膀胱炎效果观察[J].四川中医,2022,40(12):105-108. [10] 姬俊鹏,李会兵,李会平,等. 经尿道膀胱黏膜电切术联合塞来昔布治疗肠型腺性膀胱炎的临床效果[J].临床医学研究与实践,2023,8(28):74-77. [11] 关育栋,杨小明,魏晓松,等. 基于全身炎症指标和临床特征探讨腺性膀胱炎电切术后复发的危险因素[J].河南外科学杂志,2023,29(3):11-15. [12] 顾建华,刘芳,赵朱军,等. 红细胞分布宽度与腺性膀胱炎患者术后3年复发的相关性研究[J].医学研究杂志,2017,46(9):88-90. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(9): 1608-1610. |
|
|
|
|